7 March 2014 - The links to the Public Summary Documents for the recommendations and subsequent rejections from the PBAC meeting held in November 2013 have been added to MAESTrO Australia.

Insofar as the PSDs contain a lot more detail on the submissions and their related outcomes than the PBAC short minutes, some aspects of some entries in the MAESTrO Australia database may be edited/revised upon the release of the PSDs. For example, tobramycin (Tobi Podhaler) was recommended on the basis of a cost-benefit analysis (discrete choice experiment); this was not clear in the PBAC short minutes.